Cargando…
The effect of SARS-CoV-2 BNT162b2 vaccine on the symptoms of women with endometriosis
PURPOSE: As the use of the messenger RNA (mRNA) BNT162b2 (Pfizer-BioNTech) Coronavirus disease 2019 vaccine has grown, reports on menstrual changes have arisen. We aimed to examine menstrual bleeding patterns and endometriosis-associated symptoms after receiving the mRNA BNT162b2 SARS-CoV-2 vaccine...
Autores principales: | Gilan, Adi, Laster-Haim, Sarit, Rottenstreich, Amihai, Porat, Shay, Lessans, Naama, Saar, Tal D., Dior, Uri P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468530/ https://www.ncbi.nlm.nih.gov/pubmed/36098831 http://dx.doi.org/10.1007/s00404-022-06765-0 |
Ejemplares similares
-
The BNT162b2 mRNA Covid-19 vaccine does not impair sperm parameters
por: Safrai, Myriam, et al.
Publicado: (2022) -
Evaluation of the effect of previous endometriosis surgery on clinical and surgical outcomes of subsequent endometriosis surgery
por: Tummers, Fokkedien H. M. P., et al.
Publicado: (2023) -
Demographic and clinical characteristics determining patient-centeredness in endometriosis care
por: Grundström, Hanna, et al.
Publicado: (2022) -
Trends among patients with endometriosis over a 7-year period and the impact of the COVID-19 pandemic: experience from an academic high-level endometriosis centre in Germany
por: Keilmann, Lucia, et al.
Publicado: (2022) -
Laparoscopic treatment of deep endometriosis with a diode laser: our experience
por: Angioni, Stefano, et al.
Publicado: (2021)